posted on 2024-11-12, 12:46authored byDaniel Brungs
Biomarkers are critically important in clinical oncology. In addition to providing valuable prognostic information, biomarkers assist in patient risk assessment, prediction of response to treatment, and monitoring progress of disease, all key factors in improving the individualisation and delivery of treatment. Furthermore, biomarkers provide insight into the mechanisms of cancer and identify novel targets for therapeutic agents. This thesis investigates both molecular biomarkers in gastroesophageal cancer and clinical biomarkers in colon cancer and identifies several molecular targets and clinical markers of interest.
History
Year
2018
Thesis type
Doctoral thesis
Faculty/School
School of Biological Sciences
Language
English
Disclaimer
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily represent the views of the University of Wollongong.